Ruolan Qian
Shanghai Jiao Tong University(CN)Renji Hospital(CN)Shanghai Cancer Institute(CN)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Computational Drug Discovery Methods, Bioinformatics and Genomic Networks, Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Efficacy and safety of osimertinib in treating EGFR‐mutated advanced NSCLC: A meta‐analysis(2019)119 cited
- → Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer(2022)33 cited
- → Mapping the landscape of synthetic lethal interactions in liver cancer(2021)31 cited
- → Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2(2023)26 cited
- → The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis(2018)23 cited
- → The efficacy of the new medical internship management network system(2019)11 cited
- → Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer(2022)9 cited
- → A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer(2021)9 cited
- → DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma(2025)7 cited
- → Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer(2023)6 cited